Protein oxidation

Protein Reviews

Volumn 13, Issue , 2011, Pages 57-78

  Quiney, C ^a   Finnegan, S ^a   Groeger, G ^a   Cotter, T G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CASPASE; CYSTEINE; MYELOPEROXIDASE; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR; XANTHINE OXIDASE;

ALZHEIMER DISEASE; CATARACT; CATARACTOGENESIS; CELL DEATH; CELL FUNCTION; CELL SURVIVAL; CYSTIC FIBROSIS; ENZYME INACTIVATION; HUMAN; LIPID PEROXIDATION; MITOCHONDRION; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROGERIA; PROTEIN CARBONYLATION; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN OXIDATION; REVIEW;

EID: 77958470641     PISSN: 18713025     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6382-6_3     Document Type: Review

References (123)

1. Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., et al. (2001). Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103:373-383.
2. Alam, Z. I., Daniel, S. E., Lees, A. J., et al. (1997). Generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69:1326-1329.
3. Babbs, C. F. (1992). Oxygen radicals in ulcerative colitis. Free Radical Biol. Med. 13:169-181.
4. Banfi, B., Molnar, G., Maturana, A., et al. (2001). A Ca2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 276:37594-37601.
5. Banfi, B., Malgrange, B., Knisz, J., et al. (2004). NOX3, a superoxide-generating NADPH oxidase of the inner ear. J. Biol. Chem. 279:46065-46072.
6. Banfi, B., Tirone, F., Durussel, I., et al. (2004). Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5). J. Biol. Chem. 279:18583-18591.
7. Barja, G., and Herrero, A. (1998). Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon. J. Bioenerg. Biomembr. 30:235-243.
8. Barrett, W. C., DeGnore, J. P., Konig, S., et al. (1999). Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38:6699-6705.
9. Bedard, K., and Krause, K. H. (2007). The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol. Rev. 87:245-313.
10. Boscia, F., Grattagliano, I., Vendemiale G., et al. (2000). Protein oxidation and lens opacity in humans. Invest. Ophthalmol. Vis. Sci. 41:2461-2465.
11. Boueiz, A., Damarla, M., and Hassoun, P. M. (2008). Xanthine oxidoreductase in respiratory and cardiovascular disorders. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L830-L840.
12. Brennan, M. L., and Hazen, S. L. (2005). Amino acid and protein oxidation in cardiovascular disease. Amino Acids 25:365-374.
13. Butler, J., Jayson, G. G., and Swallow, A. J. (1975). Reaction between superoxide anion radical and cytochrome C. Biochim. Biophys. Acta 408:215-222.
14. Butterfield, D. A., and Stadtman, E. R. (1997). Protein oxidation processes in aging brain. Adv. Cell Aging Gerontol. 2:161-191.
15. Cakatay, U. (2005). Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab. 31:551-557.
16. Carney, J. M., Starke-Reed, P. E., Oliver, C. N., et al. (1991). Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity loss and loss of temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alphaphenylnitrone. Proc. Natl. Acad. Sci. U. S. A. 88:3633-3636.
17. 2. J. Biol. Chem. 273:32554-32560.
18. Chakravarti, B., and Chakravarti, D. N. (2007). Oxidative modification of proteins: age-related changes. Gerontology 53:128-139.
19. Chen, Y., Cai, J. Y., Murphy, T. J., et al. (2002). Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J. Biol. Chem. 277:33242-33248.
20. Cheng, G. J., Cao, Z. H., Xu, X. X., et al. (2001). Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269:131-140.
21. Chiarugi, P., Fiaschi, T., Taddei, M. L., et al. (2001). Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J. Biol. Chem. 276:33478-33487.
22. Choi, J., Sullards, M. C., Olzmann, J. A., et al. (2006). Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem. 281:10816-10824.
23. Chung, H. Y., Baek, B. S., Song, S. H., et al. (1997). Xanthine dehydrogenase, xanthine oxidase and oxidative stress. Age 20:127-140.
24. Dalle-Donne, I., Giustarini, D., Colombo, R., et al. (2003). Protein carbonylation in human diseases. Trends Mol. Med. 9:169-176.
25. Dalle-Donne, I., Aldini, G., Carini, M., et al. (2006). Protein carbonylation, cellular dysfunction, and disease progression. J. Cell. Mol. Med. 10:389-406.
26. Danielson, S. R., and Andersen, J. K. (2008). Oxidative and nitrative protein modifications in Parkinson's disease. Free Radical Biol. Med. 44:1787-1794.
27. Davies, M. J., and Truscott, R. J. (2001). Photo-oxidation of proteins and its role in cataractogenesis. J. Photochem. Photobiol. B 63:114-125.
28. Davis, P. B. O. Pathophysiology of the lung disease in cystic fibrosis. In: Davis P. B., ed. Cystic fibrosis. New York: Marcel Dekker, 1993, pp. 193-218.
29. Denu, J. M., and Dixon, J. E. (1998). Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Curr. Opin. Chem. Biol. 2:633-641.
30. Donko, A., Peterfi, Z., Sum, A., et al. (2005). Dual oxidases. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 360:2301-2308.
31. Dupuy, C., Ohayon, R., Valent, A., et al. (1999). Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cDNAs. J. Biol. Chem. 274:37265-37269.
32. Edderkaoui, M., Hong, P., Vaquero, E. C., et al. (2005). Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G1137-G1147.
33. Edens, W. A., Sharling, L., Cheng, G. J., et al. (2001). Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91 phox. J. Cell Biol. 154:879-891.
34. Esteves, A. R., Arduíno, D. M., Swerdlow, R. H., et al. (2009). Oxidative stress involvement in α-synuclein oligomerization in Parkinson disease cybrids. Antioxid. Redox Signal 11:439-448.
35. Farrer, M. J. (2006). Genetics of Parkinson disease: paradigm shifts and future prospects. Nat. Rev. Genet. 7:306-318.
36. Fetrow, J. S., Siew, N., Skolnick, J. (1999). Structure-based functional motif identifies a potential disulfide oxidoreductase active site in the serine/threonine protein phosphatase-1 subfamily. FASEB J. 13:1866-1874.
37. Fleury, C., Mignotte, B., and Vayssiere, J. L. (2002). Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84:131-141.
38. Forster, M. J., Dubey, A., Dawson, K. M., et al. (1996). Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc. Natl. Acad. Sci. U. S. A. 93:4765-4769.
39. Gao, T., Furnari, F., and Newton, A. C. (2005). PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18:13-24.
40. Geiszt, M., Kopp, J. B., Varnai, P., et al. (2000). Identification of renox, an NAD (P) H oxidase in kidney. Proc. Natl. Acad. Sci. U. S. A. 97:8010-8014.
41. Geiszt, M., Witta, J., Baffi, J., et al. (2003). Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 17:1502-1504.
42. Go, Y. M., and Jones, D. P. (2008). Redox compartmentalization in eukaryotic cells. Biochim. Biophys. Acta 1780:1271-1290.
43. Goedert, M., and Spillantini, M. G. (2006). A century of Alzheimer's disease. Science 314:777-781.
44. Guidot, D. M., Repine, J. E., Kitlowski, A. D., et al. (1995). Mitochondrial respiration scavenges extramitochondrial superoxide anion via a nonenzymatic mechanism. J. Clin. Invest. 96:1131-1136.
45. Guy, G. R., Philp, R., and Tan, Y. H. (1995). Activation of protein kinases and the inactivation of protein phosphatase 2A in tumour necrosis factor and interleukin-1 signal-transduction pathways. Eur. J. Biochem. 229:503-511.
46. Halliwell, B., and Gutteridge, J. (1999). Free radicals in biology and medicine, 3rd ed. Oxford: Oxford University Press.
47. Hampton, M. B., and Orrenius, S. (1997). Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett. 414:552-556.
48. Hennekam, R. C. (2006). Hutchinson-Gilford progeria syndrome: review of the phenotype. Am. J. Med. Genet. A, 140:2603-2624.
49. Hensley, K., Robinson, K. A., Gabbita, S. P., et al. (2000). Reactive oxygen species, cell signaling, and cell injury. Free Radical Biol. Med. 28:1456-1462.
50. Hitchon, C. A., and El-Gabalawy, H. S. (2004). Oxidation in rheumatoid arthritis. Arthritis Res. Ther. 6:265-278.
51. Hunter, T. (1995). Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signalling. Cell 80:225-236.
52. Inanami, O., Johnson, J. L., McAdara, J. K., et al. (1998). Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47 (PHOX) on serine 303 or 304. J. Biol. Chem. 273:9539-9543.
53. Iyer, G. Y., Islam, M. F., and Quastel, J. H. (1961). Biochemical aspects of phagocytosis. Nature 192:535-542.
54. Jung T., and Grune T. T. (2008). The proteasome and its role in the degeneration of oxidised proteins. IUBMB Life 60:743-752.
55. Kakkar, P., and Singh, B. K. (2007). Mitochondria: a hub of redox activities and cellular distress control. Mol. Cell. Biochem. 305:235-253.
56. Kamata, H., Manabe, T., Oka, S., et al. (2002). Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett. 519:231-237.
57. Kawahara, T., Ritsick, D., Cheng, G. J., et al. (2005). Point mutations in the proline-rich region of p22 (phox) are dominant inhibitors of Nox1-and Nox2-dependent reactive oxygen generation. J. Biol. Chem. 280:31859-31869.
58. Kieran, M. W., Gordon, L., and Kleinman, M. (2007). New approaches to Progeria. Pediatrics 120:834-841.
59. Kim, C., Kim, J. Y., and Kim, J. H. (2008). Cytosolic phospholipase A (2), lipoxygenase metabolites, and reactive oxygen species. BMB Rep. 41:555-559.
60. Klebanoff, S. J. (2005). Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77:598-625.
61. Klumpp, S., Selke, D., and Krieglstein, J. (2003). Protein phosphatase type 2C dephosphorylates BAD. Neurochem. Int. 42:555-560.
62. Kubisch, H. M., Wang, J., Luche, R., et al. (1994). Transgenetic copper/zinc superoxide dismutase modulates susceptibility to type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 91:9956-9959.
63. Kuhn, H., and Thiele, B. J. (1999). The diversity of the lipoxygenase family: Many sequence data but little information on biological significance. FEBS Lett. 449:7-11.
64. Lamb, N. J., Gutteridge, J. M., Baker, C., et al. (1999). Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: Evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Critical Care Med. 27:1738-1744.
65. Lambeth, J. D., Kawahara, T., and Diebold, B. (2007). Regulation of Nox and Duox enzymatic activity and expression. Free Radical Biol. Med. 43:319-331.
66. Lee, S. R., Kwon, K. S., Kim, S. R., et al. (1998). Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273:15366-15372.
67. Leseney, A. M., Deme, D., Legue, O., et al. (1999). Biochemical characterization of a Ca2+/NAD (P) H-dependent H2O2 generator in human thyroid tissue. Biochimie 81:373-380.
68. Levine, R. L., Mosoni, L., Berlett, B. S., et al. (1996). Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. U. S. A. 93:15036-15040.
69. Mackey, A. M., Sanvicens, N., Groeger, G., et al. (2008). Redox survival signalling in retinaderived 661W cells. Cell Death Differ. 15:1291-1303.
70. Mahadev, K., Zilbering, A., Zhu, L., et al. (2001). Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1B in vivo and enhances the early insulin action cascade. J. Biol. Chem. 276:21938-21942.
71. 2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24:1844-1854.
72. Malle, E., Furtmuller, P. G., Sattler, W., et al. (2007). Myeloperoxidase: a target for new drug development? Br. J. Pharmacol. 152:838-854.
73. Mancuso, M., Coppede, F., Migliore, L., et al. (2006). Mitochondrial dysfunction, oxidative stress and neurodegeneration. J. Alzheimer's Dis. 10:59-73.
74. Markesbery, W. R., and Carney, J. M. (1999). Oxidative alterations in Alzheimer's disease. Brain Pathol. 9:133-146.
75. Markesbery, W. R., and Lovell, M. A. (2007). Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch. Neurol. 64:954-956.
76. Meng, T. C., Fukada, T., and Tonks, N. K. (2002). Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9:387-399.
77. Millward, T. A., Zolnierowicz, S., and Hemmings, B. A. (1999). Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24:186-191.
78. Miyasaki, K. T., Song, J. P., and Murthy, A. R. K. (1991). Secretion of myeloperoxidase isoforms by human neutrophils. Anal. Biochem. 193:38-44.
79. Moncada, S., and Erusalimsky, J. D. (2002). Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell Biol. 3:214-220.
80. Murphy, M. E., and Kehrer, J. P. (1989). Oxidative stress and muscular dystrophy. Chem. Biol. Interact. 69:101-173.
81. Nawata, R., Yujiri, T., Nakamura, Y., et al. (2003). MEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-kappaB activation. Oncogene 22:7774-7780.
82. Nishino, T., Okamoto, K., Eger, B. T., et al. (2008). Mammalian xanthine oxidoreductase. Mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J. 275:3278-3289.
83. Okado-Matsumoto, A., and Fridovich, I. (2001). Subcellular distribution of superoxide dismutases (SOD) in rat liver-Cu, Zn-SOD-in mitochondria. J. Biol. Chem. 276:38388-38393.
84. Oliver, C. N., Ahn, B. W., Moerman, E. J., Goldstein, S., and Stadtman, E. R. (1987). Age-related changes in oxidized proteins. J. Biol. Chem. 262:5488-5491.
85. O'Loghlen, A., Perez-Morgado, M. I., Salinas, M. et al. (2003). Reversible inhibition of the protein phosphatase 1 by hydrogen peroxide. Potential regulation of eIF2 alpha phosphorylation in differentiated PC12 cells. Arch. Biochem. Biophys. 417:194-202.
86. Pearce, R. K., Owen, A., Daniel, S., et al. (1997). Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J. Neural Transm. 104:661-677.
87. Praticò, D., and Sung, S. (2004). Lipid peroxidation and oxidative imbalance: early functional event in Alzheimer's disease. J. Alzheimers Dis. 6:171-175.
88. Puddu, P., Puddu, G. M., Cravero, E., et al. (2008). The molecular sources of reactive oxygen species in hypertension. Blood Press.17:70-77.
89. Rahman, I., Gilmour, P. S., Jimenez, L. A. et al. (2002). Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol. Cell. Biochem. 234-235:239-248.
90. Rahman, I., Marwick, J., and Kirkham, P. (2004). Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem. Pharmacol. 68:1255-1267.
91. Rao, R. K., and Clayton, L. W. (2002). Regulation of protein phosphatase 2A by hydrogen peroxide and glutathionylation. Biochem. Biophys. Res. Commun. 293:610-616.
92. Refsgaard, H. H., Tsai, L., Stadtman, E. R. (2000). Modifications of proteins by polyunsaturated fatty acid peroxidation products. Proc. Natl. Acad. Sci. U. S. A. 97:611-616.
93. Royerpokora, B., Kunkel, L. M., Monaco, A. P., et al. (1986). Cloning the gene for an inherited human disorder-Chronic Granulomatous-Disease-on the basis of its chromosomal location. Nature 322:32-38.
94. Sadok, A., Bourgarel-Rey, V., Gattacceca, F., et al. (2008). Nox1-dependent superoxide production controls colon adenocarcinoma cell migration. Biochim. Biophys. Acta 1783:23-33.
95. Salh, B., Webb, K., Guyan, P. M., et al. (1989). Aberrant free radical activity in cystic fibrosis. Clin. Chim. Acta 181:65-74.
96. Salmeen, A., and Barford, D. (2005). Functions and mechanisms of redox regulation of cysteinebased phosphatases. Antioxid. Redox Signal. 7:560-577.
97. Savitsky, P. A., and Finkel, T. (2002). Redox regulation of Cdc25C. J. Biol. Chem. 277:20535-20540.
98. Schidlow, D. V. (2000). Newer therapies for cystic fibrosis. Paediatr. Respir. Rev. 1:107-113.
99. Shiose, A., Kuroda, J., Tsuruya, K., et al. (2001). A novel superoxide-producing NAD (P) H oxidase in kidney. J. Biol. Chem. 276:1417-1423.
100. Siew, E. L., Opalecky, D., and Bettelheim, F. A. (1981). Light scattering of normal human lens. II. Age dependence of the light scattering parameters. Exp. Eye Res. 33:603-614.
101. Smith, C. D., Carney, J. M., Starke-Reed, P. E., et al. (1991). Excess brain protein oxidation and enzyme dysfunction in normal and Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 88:10540-10543.
102. Spector, A. (1995). Oxidative stress-induced cataract: mechanism of action. FASEB J. 9:1173-1182.
103. Stadtman, E. R. (1990). Metal ion-catalyzed oxidation of proteins: biochemical mechanisms and biological consequences. Free Radical Biol. Med. 9:315-325.
104. Stadtman, E. R. (2001). Protein oxidation in aging and age-related diseases. Ann. New York Acad. Sci. 928:22-38.
105. Stadtman, E. R., and Berlett, B. S. (1997). Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol. 10:485-494.
106. Stadtman, E. R., and Levine, R. L. (2003). Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 25:207-218.
107. Starosta, V., Rietschel, E., Paul, K., et al. (2006). Oxidative changes of bronchoalveolar proteins in cystic fibrosis. Chest 129:431-437.
108. St-Pierre, J., Buckingham, J. A., Roebuck, S. J., et al. (2002). Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 277:44784-44790.
109. Suh, Y. A., Arnold, R. S., Lassegue, B., et al. (1999). Cell transformation by the superoxide-generating oxidase Mox1. Nature 401:79-82.
110. Suleyman, H., Demircan, B., and Karagoz, Y. (2007). Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol. Rep. 59:247-258.
111. Sumimoto, H. (2008). Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J. 275:3249-3277.
112. Taira, T., Saito, Y., Niki, T., et al. (2004). DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 5:213-218.
113. Tanaka, T., Hosoi, F., Yamaguchi-Iwai, Y., et al. (2002). Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 21:1695-1703.
114. Thomas, B., and Beal, M. F. (2007). Parkinson's disease. Human. Mol. Genet. 16:183-194.
115. Toledano, M. B., and Leonard, W. J. (1991). Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. U. S. A. 88:4328-4332.
116. Turrens, J. F., and Boveris, A. (1980). Generation of superoxide anion by the NADH dehydrogenase of bovine heart-mitochondria. Biochem. J. 191:421-427.
117. Turrens, J. F., Alexandre, A., and Lehninger, A. L. (1985). Ubisemiquinone is the electron-donor for superoxide formation by Complex III of heart-mitochondria. Arch. Biochem. Biophys. 237:408-414.
118. Vandermoere, F., El Yazidi-Belkoura, I., Adriaenssens, E., et al. (2005). The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappaB activation induced via interaction between Akt and IkappaB kinase-beta in breast cancer cells. Oncogene 24:5482-5491.
119. Vaquero, E. C., Edderkaoui, M., Pandol, S. J., et al. (2004). Reactive oxygen species produced by NAD (P) H oxidase inhibit apoptosis in pancreatic cancer cells. J. Biol. Chem. 279:34643-34654.
120. Vasquez-Vivar, J., Kalyanaraman, B., Martasek, P., et al. (1998). Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. U. S. A. 95:9220-9225.
121. West, S. (2007). Epidemiology of cataract: accomplishments over 25 years and future directions. Ophthalmic Epidemiol. 14:173-178.
122. Wientjes, F. B., Hsuan, J. J., Totty, N. F., et al. (1993). P40phox, a third cytosolic component of the activation complex of the NADP oxidase to contain Src homology 3 domains. Biochem. J. 296:557-561.
123. Williams, D. L. (2006). Oxidation, antioxidants and cataract formation: a literature review 1: Vet. Ophthalmol. 9:292-298.